Enovis Corporation

Financials

Flusso di cassa derivante dalle attività operative 301.94 M356.1 M-55.86 M134.99 M113.5 M217.29 M 217.29 M Flussi di cassa derivanti dalle attività di investimento -175.08 M-320.48 M-176.39 M-242.47 M-955.47 M-179.37 M -179.37 M Liquidità derivante dalle attività di finanziamento -131.65 M584.91 M-465.13 M127.8 M846.82 M-52.4 M -52.4 M Liquidità libera 187.15 M251.86 M-155.41 M12.77 M-67.21 M19.92 M 106.05 M

Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.

ENOV

Financials

Enovis Corporation

Notizie

Why Dow Jones' J&J Is Wavering Despite Its First-Quarter Beat And Raise

UBS conferma rating Buy su Enovis per prospettive di crescita

Oliver Engert, chief administrative officer, acquista azioni Enovis Corp (ENOV)

EHC Stock: Do Valuation and Expansion Trends Support a Hold Strategy?

Cigna Stock Trades Below Industry P/E: Is It Worth Holding Now?

Oliver Engert, CAO di Enovis, acquista azioni per $23.930

Engert Oliver, chief administrative officer at Enovis, buys $23,930 in ENOV

Royce Small-Cap Fund FY 2025: What Worked... And What Didn't

Royce Premier Fund FY 2025: What Worked… And What Didn’t

Wall Street Analysts Think Enovis (ENOV) Could Surge 76.62%: Read This Before Placing a Bet

Enovis alla Conferenza CG Musculoskeletal 2026: Crescita e Innovazione

Enovis at 2026 CG Musculoskeletal Conference: Strategic Growth and Innovation